Chaverra, M., George, L., Mergy, M., Waller, H., Kujawa, K., Murnion, C. Sharples, E., Thorne, J., Podgajny, N., Grindeland, A., Ueki, Y., Eiger, S., Cusick, C., Babcock, A., Carlson, G, Lefcort, F. (2017). The Familial Dysautonomia disease gene, ikbkal/Elp1, is required in the developing and adult central nervous system. Disease Models & Mechanisms, In Press

Bessen, R.A., Cameron J. Robinson C.J., Seelig, D.M., Watschke, C.P, Lowe, D., Shearin, H., Martinka S., Babcock, A.M. (2011). Transmission of chronic wasting disease identifies a prion strain causing cachexia and heart infection in hamsters PLoS One 6(12): e28026. doi:10.1371/journal.pone.0028026

journal of neuroscience research

Babcock, A.M., Standing, D., Bullshields, K., Spencer, K., Micevych, P.E., Poulsen, D.J. (2006). Over expression of hippocampal Calcium/calmodulin-dependent protein kinase II improves spatial memory. Journal of Neuroscience Research


Babcock, A.M., Standing, D. Bullshields, K., Schwartz, E., C.M. Paden, Poulsen, D.J. (2005). In vivo inhibition of hippocampal Ca2+/calmodulin-dependent protein kinase II by RNA interference. Molecular Therapy. 11:899-905.

Babcock, A.M., Wright, J., Bjerkness, D., Hartman, H. & Tall Bear, N. (2002). Effects of prior apparatus experience and novelty of testing environment on locomotor activity following MK-801. Physiology and Behavior , 77:177-181.

Babcock A.M., Everingham, A., Paden, C.M. & Kimura, M. (2002). Baclofen is neuroprotective and prevents loss of calcium/calmodulin dependent protein kinase II immunoreactivity in the ischemic gerbil hippocampus. Journal of Neuroscience Research 67:804-811.

Babcock, A.M., Liu, H. Paden, C.M., Churn, S.B. & Pittman, A. (1999). In vivo glutamate neurotoxicity is associated with reductions in calcium/calmodulin-dependent protein kinase II immunoreactivity. Journal of Neuroscience Research 56:36-43.